Systemic lupus erythematosus (SLE) predominantly affects young women in their 20s. In 40 out of 250 (16%) patients with SLE seen in our hospital disease onset occurred after the age of 50. The interval between the time of onset and diagnosis was five years in this older group compared with three years in the younger group. Arthritis, as a first symptom, was less common in the older onset group. During the foilow up a lower incidence of arthritis, malar rash, photosensitivity, and nephropathy was found in the older onset group. In contrast, this group showed an increased incidence of myositis. High titres of anti-dsDNA tended to occur less often and the incidence of anti-Ro antibodies was lower in the older onset group. These features seem to distinguish patients with older onset SLE as a particular subset.
Systemic lupus erythematosus (SLE) predominantly affects young women in their 20s. In 10-200/o of patients, however, the diagnosis is made for the first time in the fifth decade of life or later.' 2 Several investigators have reported that age at onset has a modifying effect on disease expression. In comparison with younger patients, elderly patients with SLE are reported to have a more insidious onset of disease and less common occurrence of the classic manifestations of SLE."9 Thus the correct diagnosis is often not made for several years and is established only after extensive diagnostic evaluation.2 3 It has also been noted that certain features of SLE usually associated with severity, such as nephritis or central nervous system dysfunction, are less common in patients with older-onset SLE.' 2 In addition, serological abnormalities have also been reported to be different in elderly patients. 2 The disparity in selection criteria for patient inclusion, the age limits adopted, or the defmition of age at onset make comparison of findings in previous reports very difficult.
In this study, to determine whether any relation exists between disease patterns and age at onset, we Alfons Lopez-Soto, Margarita Navarro, 1980 and 1988 were studied prospectively. All were white and met the American Rheumatism Association revised criteria for SLE. 10 In 40 the onset of disease, defined as the initial manifestation clearly attributable to SLE, occurred after the age of 50, and they represent the older onset group described in this report. The remaining 210 patients were diagnosed before the age of 50, and they represent the younger onset group. In addition, 190 patients were tested for the presence of precipitating antibodies to soluble nuclear add cytoplasmic antigens, including Ro(SSA), La(SSB), nRNP, and Sm by double immunodiffusion (Ouchterlony).
These 190 patients were also tested for the presence of antiphospholipid antibodies, including anticardiolipin antibodies and the lupus anticoagulant activity. The anticardiolipin antibodies were measured by an enzyme linked immunosorbent assay (ELISA) as described by 
Results

PATIENTS
In 40 patients (16%) disease onset occurred after the age of 50. The mean age of this group at disease onset was 58 years (range 50-78) compared with 32 years (8-48) for the younger onset patients. The interval between the time of onset and diagnosis was five years in the older group compared with three years in the younger group (p<0 05). The male/female ratio was 4/1 in the older group in contrast with 9/1 in the younger one. All women in the older group were in the menopause at disease onset.
CLINICAL MANIFESTATIONS Table 1 shows the presenting clinical manifestations for patients with disease onset before or after age 50. The older group less often showed arthritis as a first symptom (p<0005). During the follow up analysis of cumulative clinical symptoms showed that the most significant difference between these two groups was a decreased incidence of arthritis (p<0 02), malar rash (p<0 002), photosensitivity (p<0002), and nephropathy (p<0 03) in the older onset group. In contrast, this group had a significantly increased incidence of myositis (p<0 02) ( Table 3 gives the serological findings in relation to age. High titres of anti-dsDNA tended to occur less frequently in the older onset group (p<0-05), with a similar proportion of clinically active patients in both groups, indicating that titres of anti-dsDNA decreased with aging. The The incidence of antiphospholipid antibodies (anticardiolipin antibodies or lupus anticoagulant, or both) was higher in elderly patients (p<0-01). In contrast, the incidence of anti-Ro antibodies was lower in this group of patients (p<002). No significant differences were found in the incidence of the other antibodies to extractable nuclear antigens between the two groups (table 4).
Discussion
Systemic lupus erythematosus is a chronic inflammatory disorder of unknown cause with a wide spectrum of both clinical and immunological features. Although it has traditionally been considered a disease of young women, several reports have described SLE in the elderly.`9 Nevertheless, overall experience with older-onset SLE is not extensive and the precise prevalence of clinical and serological findings differs from study to study.' 2 4 6 1-19
In our series 40 out of 250 patients with SLE (16%) developed the disease after the age of 50-a prevalence similar to that noted by others' 2 4 using similar criteria for selection of patients. In addition, although some authors2 6 7 found no difference in the female/ male ratio with aging, our observations suggest that female predominance is not so pronounced in the elderly onset group.
The clinical expression of SLE in elderly patients differs in several aspects from the disease in young adults.1-9 The presenting manifestations in the patients with older onset disease are interesting, and best resemble those in patients with drug induced SLE, primary Sjogren's syndrome, or polymyalgia rheumatica. 1 4 7 8 Thus in our series musculoskeletal manifestations, including myositis mimicking polymyalgia rheumatica, were common. Although some authors' 6 7 16 have reported that serositis and pulmonary disease were the most common presenting features in their patients, we found a similar incidence of these manifestations in both groups. In addition, our patients share many similarities with other patients with older onset SLE previously reported, including a low incidence of lupus nephropathy and classical arthritis and cutaneous involvement. 1 2 7 Age also influences the serological manifestations of SLE. Lower anti-dsDNA titres were found in our patients with older onset SLE. Similar results have been reported by Wilson et al. 4 It has been suggested that antibodies to Ro and La are more prevalent in elderly patients and might be a useful aid in establishing the diagnosis of SLE.2 6 7 In our study, however, the prevalence of these antibodies tended to decrease in the older onset group. Similar results have been found by others./0 Interestingly, we found a higher prevalence of anti-Sm antibodies, both in younger and elderly patients, than previously reported in other European studies.2' We also detected a higher prevalence of antiphospholipid antibodies in the elderly group. This is in agreement with the findings of Manoussakis et al22 that anticardiolipin antibodies are commonly found in the elderly population.
Interestingly, the initial diagnosis in the older group was tardy, presumably because doctors are reluctant to diagnose SLE in elderly patients and because atypical signs and symptoms in this age group are common. This is reflected in our series in the mean five year delay in establishing the diagnosis of SLE in the older onset group. High clinical awareness is important as it is expected that increasing numbers of people will survive into the later years of life during the next decades. Thus it is reasonable to expect that more patients with older onset SLE will be diagnosed in the future.6 23 Although the explanation for this apparently age related variability in expression of the disease is still unclear, demographic factors and differences in genetic predisposition or responsiveness of an aging immune system may be implicated.3 8 It has been suggested that older and younger patients may have different genetic determinants of disease and respond to different triggering mechanisms.623 Alternatively, the less exuberant expression of SLE both clinically and immunologically in older patients may reflect senescence of the immune system. 24 Our knowledge of the clinical and epidemiological aspects of SLE in the elderly has increased substantially in the last few years. Many questions await further analysis from a genetic and immunological perspective, however.
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